[Care of adult patients with epileptic seizure in emergency departments (ACESUR Registry). Differences according to age ≥75 years].

Objectives: To determine whether there are differences in the profile and in the care of adult patients with epileptic seizures in emergency department according to age ≥75 years, and if this is independently associated with results in the emergency department and 30 days after discharge.

Material And Methods: ACESUR is a multicentre, prospective, observational cohort multipurpose register that was carried out in 2017. The distribution of the variables corresponding to the clinical presentation and care according to age ≥75 years were compared.

A randomised controlled trial on the efficacy of a multidisciplinary health care team on morbidity and mortality of elderly patients attending the Emergency Department. Study design and preliminary results.

Objective: To estimate the prevalence of potentially inadequate drug prescriptions in elderly patients who attend the Emergency Department.

Design: A multicentre randomized clinical trial. Patients over 65 years of age attending the Emergency Department are randomized to the control arm or the intervention arm.

[Clinical profile and 90-day mortality in centenarian patients attended in emergency departments].

Objectives: To determine the clinical profile and to develop a model to predict 90-day mortality in centenarian patients attended in emergency departments (ED).

Methodology: This was an observational, retrospective, multicentre cohort study including patients >99years attended in 5 ED in the Community of Madrid from January to December 2012. Demographic variables were recorded, as well as, comorbidities, cognitive, functional, social basal status, geriatric syndromes, acute episode, and hospital and social resources use, and 90-day mortality.

[Recomendations for the prevention of adverse drug reactions in older adults with dementia].

The elderly are one of the groups at greatest risk for adverse drugs reactions (ADR). The mean prevalence of these reactions in this population is 30%. Dementia is not an independent risk factor of ADR, but is the main condition that increases all risk factors (polypharmacy, comorbidity, inappropriate prescribing, drug-drug interactions, advanced age, and treatment adherence).